INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $104,000 | +4.0% | 46,103 | +57.0% | 0.00% | – |
| Q3 2021 | $100,000 | +222.6% | 29,361 | +186.9% | 0.00% | – |
| Q2 2021 | $31,000 | +210.0% | 10,234 | -2.2% | 0.00% | – |
| Q4 2019 | $10,000 | -86.8% | 10,463 | -75.2% | 0.00% | – |
| Q2 2019 | $76,000 | +153.3% | 42,114 | +117.6% | 0.00% | – |
| Q3 2016 | $30,000 | -81.0% | 19,355 | +3.6% | 0.00% | – |
| Q3 2015 | $158,000 | +22.5% | 18,674 | +59.0% | 0.00% | – |
| Q2 2015 | $129,000 | -58.5% | 11,742 | -47.3% | 0.00% | -100.0% |
| Q1 2015 | $311,000 | -16.6% | 22,279 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $373,000 | +56.1% | 22,109 | +24.0% | 0.00% | 0.0% |
| Q3 2014 | $239,000 | -15.8% | 17,830 | -19.9% | 0.00% | 0.0% |
| Q2 2014 | $284,000 | +72.1% | 22,267 | +60.4% | 0.00% | – |
| Q1 2014 | $165,000 | – | 13,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |